featured
Clinical Risk Factors for Immune Checkpoint Inhibitor–Induced Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes
Diabetes Care 2022 Mar 03;[EPub Ahead of Print], X Chen, AH Affinati, Y Lee, AF Turcu, NL Henry, E Schiopu, A Qin, M Othus, D Clauw, N Ramnath, L ZhaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.